Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 7 studies | 30% ± 15% | |
endothelial cell | 4 studies | 24% ± 7% | |
epithelial cell | 4 studies | 26% ± 13% | |
astrocyte | 4 studies | 26% ± 5% | |
glutamatergic neuron | 4 studies | 43% ± 15% | |
microglial cell | 3 studies | 17% ± 0% | |
retinal cone cell | 3 studies | 23% ± 2% | |
GABAergic neuron | 3 studies | 32% ± 9% | |
endothelial cell of lymphatic vessel | 3 studies | 21% ± 3% | |
type I pneumocyte | 3 studies | 22% ± 5% | |
macrophage | 3 studies | 17% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 33% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 3808.86 | 21 / 21 | 100% | 24.59 | 504 / 504 |
esophagus | 100% | 3030.98 | 1445 / 1445 | 100% | 27.90 | 183 / 183 |
prostate | 100% | 2498.43 | 245 / 245 | 100% | 19.56 | 501 / 502 |
lung | 100% | 2342.93 | 577 / 578 | 100% | 20.59 | 1154 / 1155 |
stomach | 100% | 1997.36 | 359 / 359 | 100% | 23.60 | 285 / 286 |
breast | 100% | 1932.28 | 459 / 459 | 100% | 21.85 | 1114 / 1118 |
intestine | 100% | 3173.70 | 966 / 966 | 100% | 23.65 | 525 / 527 |
ovary | 100% | 1711.72 | 180 / 180 | 99% | 18.77 | 427 / 430 |
brain | 100% | 1773.60 | 2631 / 2642 | 99% | 12.76 | 700 / 705 |
thymus | 100% | 2346.76 | 653 / 653 | 99% | 15.53 | 598 / 605 |
uterus | 100% | 2238.46 | 170 / 170 | 99% | 22.01 | 453 / 459 |
skin | 100% | 2526.88 | 1809 / 1809 | 99% | 20.25 | 465 / 472 |
kidney | 100% | 1593.22 | 89 / 89 | 97% | 12.62 | 875 / 901 |
pancreas | 97% | 827.70 | 317 / 328 | 99% | 15.91 | 176 / 178 |
adrenal gland | 100% | 1500.98 | 258 / 258 | 94% | 11.61 | 216 / 230 |
liver | 78% | 473.87 | 176 / 226 | 72% | 7.17 | 294 / 406 |
adipose | 100% | 2014.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2406.15 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.50 | 29 / 29 |
spleen | 100% | 1939.34 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.38 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.81 | 1 / 1 |
muscle | 100% | 2663.28 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1208.44 | 835 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 1762.64 | 872 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 11.74 | 74 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035646 | Biological process | endosome to melanosome transport |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0032456 | Biological process | endocytic recycling |
GO_0048812 | Biological process | neuron projection morphogenesis |
GO_0050775 | Biological process | positive regulation of dendrite morphogenesis |
GO_0035544 | Biological process | negative regulation of SNARE complex assembly |
GO_0015031 | Biological process | protein transport |
GO_0045022 | Biological process | early endosome to late endosome transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005769 | Cellular component | early endosome |
GO_0097422 | Cellular component | tubular endosome |
GO_0005764 | Cellular component | lysosome |
GO_0043005 | Cellular component | neuron projection |
GO_0005829 | Cellular component | cytosol |
GO_0005770 | Cellular component | late endosome |
GO_0030133 | Cellular component | transport vesicle |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0042470 | Cellular component | melanosome |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0031267 | Molecular function | small GTPase binding |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0000149 | Molecular function | SNARE binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ANKRD27 |
Protein name | Ankyrin repeat domain 27 Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein) |
Synonyms | PP12899 |
Description | FUNCTION: May be a guanine exchange factor (GEF) for Rab21, Rab32 and Rab38 and regulate endosome dynamics . May regulate the participation of VAMP7 in membrane fusion events; in vitro inhibits VAMP7-mediated SNARE complex formation by trapping VAMP7 in a closed, fusogenically inactive conformation . Involved in peripheral melanosomal distribution of TYRP1 in melanocytes; the function, which probably is implicating vesicle-trafficking, includes cooperation with Rab32, Rab38 and VAMP7 (By similarity). Involved in the regulation of neurite growth; the function seems to require its GEF activity, probably towards Rab21, and VAMP7 but not Rab32/38 (By similarity). Proposed to be involved in Golgi sorting of VAMP7 and transport of VAMP7 vesicles to the cell surface; the function seems to implicate kinesin heavy chain isoform 5 proteins, GOLGA4, RAB21 and MACF1 . Required for the colocalization of VAMP7 and Rab21, probably on TGN sites . Involved in GLUT1 endosome-to-plasma membrane trafficking; the function is dependent of association with VPS29 . Regulates the proper trafficking of melanogenic enzymes TYR, TYRP1 and DCT/TYRP2 to melanosomes in melanocytes (By similarity). . |
Accessions | ENST00000586463.5 K7EIN0 ENST00000587352.5 K7ENE0 K7ELM1 K7EPM2 ENST00000588700.5 Q96NW4 ENST00000306065.9 ENST00000590519.2 V9GYL8 K7EIH4 ENST00000586693.7 ENST00000591100.6 |